A conserved protein O-glycosylation pathway in the Burkholderia genus essential for bacterial fitness and antigenicity in humans
伯克霍尔德氏菌属中保守的蛋白质 O-糖基化途径对于人类细菌适应性和抗原性至关重要
基本信息
- 批准号:BB/T005807/1
- 负责人:
- 金额:$ 58.1万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The Burkholderia genus includes bacteria widely distributed around the planet, which can survive in diverse environments and in association with diverse hosts. Some of the Burkholderia species are particularly dangerous to humans, as they cause disseminated and often lethal infections such as melioidosis (B. pseudomallei) and glanders (B. mallei), and are also classified as category B organisms due their potential use as biological warfare agents. Other Burkholderia species (e.g. B. cenocepacia and B. multivorans), cause debilitating lung infections in cystic fibrosis patients. On the other hand, Burkholderia species are highly useful for bioremediation, plant growth promotion, and pest biocontrol. Preventing Burkholderia infections in susceptible people will eliminate the threat of Burkholderia for humans and make it possible to better exploit the multiple beneficial aspects of these bacteria. We have characterised a protein glycosylation pathway conserved in all Burkholderia that allows the possibility to develop a universal Burkholderia vaccine. The Burkholderia protein glycosylation pathway is encoded by genes conserved in all Burkholderia species, and consists of proteins involved in stitching sugars together in a particular sequence to form an oligosaccharide molecule, which is then incorporated to several bacterial proteins that are located on the bacterial cell envelope. We are in the process to establishing the carbohydrate structure of the oligosaccharide attached to at least 23 Burkholderia proteins, and have elucidated the genes required for oligosaccharide assembly and export. Our research team also discovered that sera from Burkholderia-infected patients suffering from cystic fibrosis (B. cenocepacia and B. multivorans), melioidosis (B. pseudomallei) and glanders (B. mallei) have antibodies that specifically recognize a glycosylated protein purified from B. cenocepacia, indicating that glycosylated Burkholderia proteins are perceived by the human immune system. To test whether immunization with a Burkholderia glycosylated protein stimulates a protective immune response, groups of mice were immunized against a glycosylated protein purified from B. cenocepacia, which was also mixed with Alum, a clinically used vaccine antigen. Mice were protected from infection upon intraperitoneal challenge with B. multivorans, also indicating that the vaccine elicits cross-protection against different Burkholderia species. This proposal underpins fundamental studies at the forefront of microbial glycobiology, molecular biology and glycochemistry research with the goals to: (i) Decode the functions of the enzymes involved in the Burkholderia protein glycosylation pathway and elucidate the molecular structure of the oligosaccharide glycan; (ii) Elucidate the mechanism behind the physiological alterations due to loss of protein glycosylation in bacteria; and (iii) Determine the structure function of the oligosaccharyltransferase PglL to enable biotechnological applications through glycoengineering approaches. Aligned to the BBSRC roadmap, this innovative project rises to the challenges of finding novel means to deal with dangerous opportunistic pathogens by advancing biotechnological research elucidating the protein glycosylation system in Burkholderia and exploiting this knowledge to develop wide-spectrum vaccine. It also fits well with the need to find alternatives to antibiotics for the control of multidrug resistant bacteria, such as the Burkholderia, by exposing new ways to prevent infection by these bacteria in susceptible patients.
伯克霍尔德氏菌属包括广泛分布在地球上的细菌,它们可以在不同的环境中生存,并与不同的宿主相关联。一些伯克霍尔德菌属物种对人类特别危险,因为它们引起播散性且通常致命的感染,如类鼻疽病(B.假鼻疽)和鼻疽(B.鼻疽),并且由于其作为生物战剂的潜在用途,也被分类为B类生物。其他伯克霍尔德氏菌属种(例如B. cenocepacia和B.多噬菌体),在囊性纤维化患者中引起使人衰弱的肺部感染。另一方面,伯克霍尔德氏菌物种对于生物修复、植物生长促进和害虫生物防治非常有用。在易感人群中预防伯克霍尔德菌感染将消除伯克霍尔德菌对人类的威胁,并使人们有可能更好地利用这些细菌的多个有益方面。我们已经表征了在所有伯克霍尔德氏菌中保守的蛋白质糖基化途径,这使得开发通用伯克霍尔德氏菌疫苗的可能性。伯克霍尔德氏菌蛋白糖基化途径由所有伯克霍尔德氏菌属物种中保守的基因编码,并且由参与将糖以特定序列拼接在一起以形成寡糖分子的蛋白质组成,寡糖分子然后掺入位于细菌细胞包膜上的几种细菌蛋白质。我们正在建立至少23种伯克霍尔德氏菌蛋白质所附着的低聚糖的碳水化合物结构,并已阐明低聚糖组装和输出所需的基因。我们的研究小组还发现,来自感染伯克霍尔德氏菌的囊性纤维化患者(B. cenocepacia和B.多噬菌)、类鼻疽(B.假鼻疽)和鼻疽(B.鼻疽)具有特异性识别从B纯化的糖基化蛋白的抗体。cenocepacia,表明糖基化伯克霍尔德氏菌蛋白被人类免疫系统感知。为了测试用伯克霍尔德氏菌糖基化蛋白免疫是否刺激保护性免疫应答,用从B纯化的糖基化蛋白免疫小鼠组。cenocepacia,其还与明矾(临床上使用的疫苗抗原)混合。在用B腹膜内攻击后,保护小鼠免受感染。多噬菌体,也表明该疫苗增强了针对不同伯克霍尔德氏菌属物种的交叉保护。这一提议支持了微生物糖生物学、分子生物学和糖化学研究前沿的基础研究,其目标是:(i)解码参与伯克霍尔德氏菌蛋白糖基化途径的酶的功能,并阐明寡糖聚糖的分子结构;(ii)阐明细菌中蛋白糖基化丧失导致生理改变的机制;(iii)阐明细菌中蛋白糖基化丧失导致生理改变的机制。和(iii)确定寡糖基转移酶PglL的结构功能,以通过糖工程方法实现生物技术应用。根据BBSRC路线图,这个创新项目通过推进生物技术研究来阐明伯克霍尔德氏菌中的蛋白质糖基化系统,并利用这些知识开发广谱疫苗,从而应对寻找新方法来应对危险的机会致病菌的挑战。它也很好地符合需要找到抗生素的替代品,以控制多重耐药细菌,如伯克霍尔德氏菌,通过暴露新的方法来预防易感患者感染这些细菌。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bacterial conversion of a host weapon into a nutritional signal.
- DOI:10.1016/j.jbc.2022.102600
- 发表时间:2022-11
- 期刊:
- 影响因子:4.8
- 作者:Valvano, Miguel A.
- 通讯作者:Valvano, Miguel A.
Exploring the Topology of Cytoplasmic Membrane Proteins Involved in Lipopolysaccharide Biosynthesis by in Silico and Biochemical Analyses.
通过计算机模拟和生化分析探索参与脂多糖生物合成的细胞质膜蛋白的拓扑结构。
- DOI:10.1007/978-1-0716-2581-1_5
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Monjarás Feria J
- 通讯作者:Monjarás Feria J
Polymyxin Resistance and Heteroresistance Are Common in Clinical Isolates of Achromobacter Species and Correlate with Modifications of the Lipid A Moiety of Lipopolysaccharide.
- DOI:10.1128/spectrum.03729-22
- 发表时间:2023-02-14
- 期刊:
- 影响因子:3.7
- 作者:
- 通讯作者:
Current Advances in Burkholderia Vaccines Development.
- DOI:10.3390/cells9122671
- 发表时间:2020-12-11
- 期刊:
- 影响因子:6
- 作者:Wang G;Zarodkiewicz P;Valvano MA
- 通讯作者:Valvano MA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Miguel Valvano其他文献
Miguel Valvano的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Miguel Valvano', 18)}}的其他基金
Love/hate relationships of Achromobacter species and human macrophages
无色杆菌属与人类巨噬细胞的爱/恨关系
- 批准号:
BB/Y00440X/1 - 财政年份:2024
- 资助金额:
$ 58.1万 - 项目类别:
Research Grant
Discovery Projects - Grant ID: DP210100362
发现项目 - 拨款 ID:DP210100362
- 批准号:
ARC : DP210100362 - 财政年份:2021
- 资助金额:
$ 58.1万 - 项目类别:
Discovery Projects
Bacterial lipocalins: Novel role in bacterial protection against antibiotic-induced membrane lipid peroxidation
细菌脂质运载蛋白:在防止抗生素诱导的膜脂过氧化的细菌保护中的新作用
- 批准号:
BB/S006281/1 - 财政年份:2019
- 资助金额:
$ 58.1万 - 项目类别:
Research Grant
Burkholderia species in sugarcane: the relationship among antifungal production, intrinsic antimicrobial resistance, and pest biocontrol
甘蔗中的伯克霍尔德氏菌:抗真菌生产、内在抗菌素耐药性和害虫生物防治之间的关系
- 批准号:
BB/R022607/1 - 财政年份:2018
- 资助金额:
$ 58.1万 - 项目类别:
Research Grant
A novel family of type VI-secreted toxins affecting Rho GTPases, actin dynamics and inflammation
影响 Rho GTP 酶、肌动蛋白动力学和炎症的 VI 型分泌毒素的新家族
- 批准号:
MR/P022480/1 - 财政年份:2017
- 资助金额:
$ 58.1万 - 项目类别:
Research Grant
相似国自然基金
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
- 批准号:32372636
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
- 批准号:82371054
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
- 批准号:82370976
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
- 批准号:82371660
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
- 批准号:82371798
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
- 批准号:82370865
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
- 批准号:82370885
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
- 批准号:82371738
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
- 批准号:82370954
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
相似海外基金
Cellular Mechanisms of Neuroligin-4 Gene in Human Neurons
Neuroligin-4 基因在人类神经元中的细胞机制
- 批准号:
10552576 - 财政年份:2022
- 资助金额:
$ 58.1万 - 项目类别:
Structure and function of nucleotide sugar transporters.
核苷酸糖转运蛋白的结构和功能。
- 批准号:
10595005 - 财政年份:2019
- 资助金额:
$ 58.1万 - 项目类别:
Beyond the Active Site: Structure Informed Novel Regulatory Mechanisms and Functional Modulation of O-GlcNAc Transferase
超越活性位点:O-GlcNAc 转移酶的结构知情新型调控机制和功能调节
- 批准号:
10752894 - 财政年份:2017
- 资助金额:
$ 58.1万 - 项目类别:
Biology of the HMW1 and HMW2 Adhesins of H. Influenzae
流感嗜血杆菌 HMW1 和 HMW2 粘附素的生物学
- 批准号:
7850275 - 财政年份:2009
- 资助金额:
$ 58.1万 - 项目类别:
Characterization of mammalian COG complex-interacting Golgi trafficking machinery
哺乳动物 COG 复杂相互作用的高尔基体运输机制的表征
- 批准号:
10658337 - 财政年份:2008
- 资助金额:
$ 58.1万 - 项目类别: